Agency Information Collection Activities: Submission for OMB Review; Comment Request, 10260 [E9-5029]

Download as PDF 10260 Federal Register / Vol. 74, No. 45 / Tuesday, March 10, 2009 / Notices Programs, National Library of Medicine, NIH, 6705 Rockledge Drive, Suite 301, Bethesda, MD 20892–7968, (301) 594–4937, huangz@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.879, Medical Library Assistance, National Institutes of Health, HHS) Dated: March 3, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–4975 Filed 3–9–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Submission for OMB Review; Comment Request Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a summary of information collection requests under OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer on (240) 276–1243. Proposed Project: Enhancing Substance Abuse Treatment Services To Address Hepatitis Infection Among Intravenous Drug Users Hepatitis Testing and Vaccine Tracking Form—In Use Without OMB Approval The Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Treatment (CSAT) is requesting an OMB approval of a Hepatitis Testing and Vaccine Tracking Form for the prevention of Viral Hepatitis in patients in designated OTPs. This form is similar to the Minority AIDS Initiative HIV Rapid Testing Clinical Form that received an emergency approval (OMB No. 0930–0295) in September 2008. This form will allow SAMHSA/CSAT to collect essential Clinical information that will be used for quality assurance, quality performance and product monitoring on approximately 264 Rapid Hepatitis C Test kits and 10,628 doses of hepatitis vaccine (Twinrix, HAV, or HBV). The above kits and vaccines will be provided to designated OTPs serving the minority population in their communities. The information collected on the Form will solicit and reflect the following information: • Demographics (age, gender, ethnicity) of designated OTP site. • History (screening) of Hepatitis C exposure. • Results of Rapid Hepatitis C Testing (Kit) and follow-up information. • Service provided (type of vaccine given) Divalent vaccine (Twinrix— combination HAV and HBV) or Monovalent vaccine (HAV or/and HBV). • Substance abuse treatment outcomes (information regarding the beginning, continuing or completion of vaccination series). • Type of referral services indicated (i.e., Gastroenterology, TB; Mental Health, Counseling, Reproductive/ Prenatal, etc.). This program is authorized under Section 509 of the Public Health Service (PHS) Act [42 U.S.C. 290bb-2]. The purpose of the form is to increase the screening and reporting of viral hepatitis in high risk minorities in OTPs. The information collected will allow SAMHSA to address the increased morbidity and mortality of hepatitis in minorities being treated for drug addiction. The SAMHSA/CSAT Hepatitis Testing and Vaccine Tracking Form would support quality of care, provide minimum but adequate clinical and product monitoring, and provide appropriate safeguards against fraud, waste and abuse of Federal funds. The table below reflects the annualized hourly burden. Number of respondents screened Responses/ respondent Burden hours Total burden hours 50,000 .......................................................................................................................................... 1 0.05 2,500 Written comments and recommendations concerning the proposed information collection should be sent by April 9, 2009 to: SAMHSA Desk Officer, Human Resources and Housing Branch, Office of Management and Budget, New Executive Office Building, Room 10235, Washington, DC 20503; due to potential delays in OMB’s receipt and processing of mail sent through the U.S. Postal Service, respondents are encouraged to submit comments by fax to: 202–395–6974. Dated: February 27, 2009. Elaine Parry, Director, Office of Program Services. [FR Doc. E9–5029 Filed 3–9–09; 8:45 am] BILLING CODE 4162–20–P VerDate Nov<24>2008 15:20 Mar 09, 2009 Jkt 217001 DEPARTMENT OF HOMELAND SECURITY U.S. Citizenship and Immigration Services Agency Information Collection Activities: Form I–102, Extension of a Currently Approved Information Collection; Comment Request ACTION: 60-Day Notice of Information Collection Under Review: Form I–102, Application for Replacement/Initial Nonimmigrant Arrival-Departure Document; OMB Control No. 1615– 0079. The Department of Homeland Security, U.S. Citizenship and Immigration Services (USCIS) has submitted the following information collection request for review and clearance in accordance with the Paperwork Reduction Act of 1995. The information collection is published to obtain comments from the public and PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 affected agencies. Comments are encouraged and will be accepted for sixty days until May 11, 2009. Written comments and suggestions regarding items contained in this notice, and especially with regard to the estimated public burden and associated response time should be directed to the Department of Homeland Security (DHS), USCIS, Chief, Regulatory Management Division, Clearance Office, 111 Massachusetts Avenue, NW., Suite 3008, Washington, DC 20529–2210. Comments may also be submitted to DHS via facsimile to 202–272–8352, or via e-mail at rfs.regs@dhs.gov. When submitting comments by e-mail, add the OMB Control Number 1615–0079 in the subject box. During this 60-day period USCIS will be evaluating whether to revise the Form I–102. Should USCIS decide to revise the Form I–102 it will advise the public when it publishes the 30-day notice in the Federal Register in accordance with the Paperwork Reduction Act. The public will then E:\FR\FM\10MRN1.SGM 10MRN1

Agencies

[Federal Register Volume 74, Number 45 (Tuesday, March 10, 2009)]
[Notices]
[Page 10260]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-5029]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Agency Information Collection Activities: Submission for OMB 
Review; Comment Request

    Periodically, the Substance Abuse and Mental Health Services 
Administration (SAMHSA) will publish a summary of information 
collection requests under OMB review, in compliance with the Paperwork 
Reduction Act (44 U.S.C. Chapter 35). To request a copy of these 
documents, call the SAMHSA Reports Clearance Officer on (240) 276-1243.

Proposed Project: Enhancing Substance Abuse Treatment Services To 
Address Hepatitis Infection Among Intravenous Drug Users Hepatitis 
Testing and Vaccine Tracking Form--In Use Without OMB Approval

    The Substance Abuse and Mental Health Services Administration's 
(SAMHSA) Center for Substance Abuse Treatment (CSAT) is requesting an 
OMB approval of a Hepatitis Testing and Vaccine Tracking Form for the 
prevention of Viral Hepatitis in patients in designated OTPs. This form 
is similar to the Minority AIDS Initiative HIV Rapid Testing Clinical 
Form that received an emergency approval (OMB No. 0930-0295) in 
September 2008.
    This form will allow SAMHSA/CSAT to collect essential Clinical 
information that will be used for quality assurance, quality 
performance and product monitoring on approximately 264 Rapid Hepatitis 
C Test kits and 10,628 doses of hepatitis vaccine (Twinrix, HAV, or 
HBV). The above kits and vaccines will be provided to designated OTPs 
serving the minority population in their communities. The information 
collected on the Form will solicit and reflect the following 
information:
     Demographics (age, gender, ethnicity) of designated OTP 
site.
     History (screening) of Hepatitis C exposure.
     Results of Rapid Hepatitis C Testing (Kit) and follow-up 
information.
     Service provided (type of vaccine given) Divalent vaccine 
(Twinrix--combination HAV and HBV) or Monovalent vaccine (HAV or/and 
HBV).
     Substance abuse treatment outcomes (information regarding 
the beginning, continuing or completion of vaccination series).
     Type of referral services indicated (i.e., 
Gastroenterology, TB; Mental Health, Counseling, Reproductive/Prenatal, 
etc.).

This program is authorized under Section 509 of the Public Health 
Service (PHS) Act [42 U.S.C. 290bb-2].
    The purpose of the form is to increase the screening and reporting 
of viral hepatitis in high risk minorities in OTPs. The information 
collected will allow SAMHSA to address the increased morbidity and 
mortality of hepatitis in minorities being treated for drug addiction.
    The SAMHSA/CSAT Hepatitis Testing and Vaccine Tracking Form would 
support quality of care, provide minimum but adequate clinical and 
product monitoring, and provide appropriate safeguards against fraud, 
waste and abuse of Federal funds.
    The table below reflects the annualized hourly burden.

----------------------------------------------------------------------------------------------------------------
                                                                  Responses/                       Total burden
                Number of respondents screened                    respondent      Burden hours        hours
----------------------------------------------------------------------------------------------------------------
50,000.......................................................               1             0.05            2,500
----------------------------------------------------------------------------------------------------------------

    Written comments and recommendations concerning the proposed 
information collection should be sent by April 9, 2009 to: SAMHSA Desk 
Officer, Human Resources and Housing Branch, Office of Management and 
Budget, New Executive Office Building, Room 10235, Washington, DC 
20503; due to potential delays in OMB's receipt and processing of mail 
sent through the U.S. Postal Service, respondents are encouraged to 
submit comments by fax to: 202-395-6974.

    Dated: February 27, 2009.
Elaine Parry,
Director, Office of Program Services.
[FR Doc. E9-5029 Filed 3-9-09; 8:45 am]
BILLING CODE 4162-20-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.